Ocular and Systemic Risk Markers for Development of Macular Edema and Proliferative Retinopathy in Type 2 Diabetes: A 5-Year Longitudinal Study

Overview

Journal Diabetes Care

Specialty Endocrinology

Date 2020 Nov 7

PMID 33158947

Citations 7

Authors

Antonio C-V Martinho

Ines P Marques

Ana L Messias

Torcato Santos

Maria H Madeira

David C Sousa

Conceicao Lobo

Jose Cunha-Vaz

Affiliations

Soon will be listed here.

Citing Articles

Angiographic biomarkers are significant predictors of treatment response to intravitreal aflibercept in diabetic macular edema.

Hein M, Vukmirovic A, Constable I, Raja V, Athwal A, Freund K Sci Rep. 2023; 13(1):8128.

PMID: 37208427 PMC: 10199070. DOI: 10.1038/s41598-023-35286-2.

Different Risk Profiles for Progression of Nonproliferative Diabetic Retinopathy: A 2-Year Study.

Marques I, Ribeiro M, Santos T, Mendes L, Reste-Ferreira D, Santos A Ophthalmol Ther. 2022; 12(1):485-500.

PMID: 36495395 PMC: 9834451. DOI: 10.1007/s40123-022-00623-7.

Perspectives of diabetic retinopathy-challenges and opportunities.

Sivaprasad S, Sen S, Cunha-Vaz J Eye (Lond). 2022; 37(11):2183-2191.

PMID: 36494431 PMC: 10366207. DOI: 10.1038/s41433-022-02335-5.

Characterisation of progression of macular oedema in the initial stages of diabetic retinopathy: a 3-year longitudinal study.

Lobo C, Santos T, Marques I, Madeira M, Santos A, Figueira J Eye (Lond). 2022; 37(2):313-319.

PMID: 35066579 PMC: 9873671. DOI: 10.1038/s41433-022-01937-3.

Characterization of One-Year Progression of Risk Phenotypes of Diabetic Retinopathy.

Ribeiro L, Marques I, Coimbra R, Santos T, Madeira M, Santos A Ophthalmol Ther. 2021; 11(1):333-345.

PMID: 34865186 PMC: 8770718. DOI: 10.1007/s40123-021-00437-z.

References

Atchison E, Barkmeier A . The Role of Systemic Risk Factors in Diabetic Retinopathy. Curr Ophthalmol Rep. 2017; 4(2):84-89. PMC: 5432556. DOI: 10.1007/s40135-016-0098-8. View

Marques I, Madeira M, Messias A, Santos T, Martinho A, Figueira J . Retinopathy Phenotypes in Type 2 Diabetes with Different Risks for Macular Edema and Proliferative Retinopathy. J Clin Med. 2020; 9(5). PMC: 7290313. DOI: 10.3390/jcm9051433. View